abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
Total Liabilities
$2.40M
Quarterly · Period ending: · USD
HQL Total Liabilities
Latest reported$2.40Mperiod ending
Latest reported$2.40Mperiod ending
HQL Quarterly Total Liabilities ($600.00K → $2.40M)
Quarterly total liabilities
High-resolution chart · PNG
HQL total liabilities history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Liabilities (USD) |
|---|---|
| 2,399,385 | |
| 1,726,055 | |
| 15,399,870 | |
| 888,610 | |
| 879,912 | |
| 666,959 | |
| 10,043,509 | |
| 16,823,005 | |
| 12,936,347 | |
| 10,745,112 | |
| 649,627 | |
| 595,185 | |
| 585,187 | |
| 3,330,580 | |
| 1,843,690 | |
| 2,977,801 | |
| 687,169 | |
| 1,981,675 | |
| 554,403 | |
| 2,660,033 | |
| 655,806 | |
| 5,013,951 | |
| 7,551,448 | |
| 754,555 | |
| 539,299 | |
| 530,119 | |
| 1,260,172 | |
| 404,668 | |
| 1,000,000 | |
| 3,200,000 | |
| 5,400,000 | |
| 10,950,000 | |
| 16,500,000 | |
| 9,850,000 | |
| 3,200,000 | |
| 2,150,000 | |
| 1,100,000 | |
| 1,900,000 | |
| 2,700,000 | |
| 1,850,000 | |
| 1,000,000 | |
| 1,150,000 | |
| 1,300,000 | |
| 1,950,000 | |
| 2,600,000 | |
| 1,450,000 | |
| 300,000 | |
| 550,000 | |
| 800,000 | |
| 1,400,000 | |
| 200,000 | |
| 400,000 | |
| 600,000 |